These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 29239896

  • 1. Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.
    Neogi U, Singh K, Aralaguppe SG, Rogers LC, Njenda DT, Sarafianos SG, Hejdeman B, Sönnerborg A.
    AIDS; 2018 Feb 20; 32(4):469-476. PubMed ID: 29239896
    [Abstract] [Full Text] [Related]

  • 2. Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir.
    Oliveira M, Ibanescu RI, Anstett K, Mésplède T, Routy JP, Robbins MA, Brenner BG, Montreal Primary HIV (PHI) Cohort Study Group.
    Retrovirology; 2018 Aug 17; 15(1):56. PubMed ID: 30119633
    [Abstract] [Full Text] [Related]

  • 3. Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants.
    Smith SJ, Zhao XZ, Burke TR, Hughes SH.
    Retrovirology; 2018 May 16; 15(1):37. PubMed ID: 29769116
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1.
    Hassounah SA, Alikhani A, Oliveira M, Bharaj S, Ibanescu RI, Osman N, Xu HT, Brenner BG, Mesplède T, Wainberg MA.
    Antimicrob Agents Chemother; 2017 Dec 16; 61(12):. PubMed ID: 28923862
    [Abstract] [Full Text] [Related]

  • 7. Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials.
    You J, Wang H, Huang X, Qin Z, Deng Z, Luo J, Wang B, Li M.
    PLoS One; 2016 Dec 16; 11(8):e0160087. PubMed ID: 27532886
    [Abstract] [Full Text] [Related]

  • 8. HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants.
    Smith SJ, Zhao XZ, Passos DO, Lyumkis D, Burke TR, Hughes SH.
    Antimicrob Agents Chemother; 2020 Aug 20; 64(9):. PubMed ID: 32601157
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors.
    Isaacs D, Mikasi SG, Obasa AE, Ikomey GM, Shityakov S, Cloete R, Jacobs GB.
    Viruses; 2020 Aug 26; 12(9):. PubMed ID: 32858802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.
    Liang J, Mesplède T, Oliveira M, Anstett K, Wainberg MA.
    J Virol; 2015 Nov 26; 89(22):11269-74. PubMed ID: 26311878
    [Abstract] [Full Text] [Related]

  • 14. HIV drug resistance against strand transfer integrase inhibitors.
    Anstett K, Brenner B, Mesplede T, Wainberg MA.
    Retrovirology; 2017 Jun 05; 14(1):36. PubMed ID: 28583191
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance.
    Mbhele N, Chimukangara B, Gordon M.
    Int J Antimicrob Agents; 2021 May 05; 57(5):106343. PubMed ID: 33852932
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout.
    Osman N, Mesplède T, Oliveira M, Hassounah S, Wainberg MA, Brenner BG.
    AIDS; 2018 Aug 24; 32(13):1773-1780. PubMed ID: 29894388
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.